Untargeted Metabolomic Approach to Study the Serum Metabolites in Women with Polycystic Ovary Syndrome

August 2021 in “ BMC Medical Genomics ”

Yingyan Yu, Panli Tan, Zhenchao Zhuang, Zhejiong Wang, Linchao Zhu, Ruyi Qiu, Huaxi Xu

polycystic ovary syndrome PCOS serum metabolites triacylglycerols glycerophosphocholines acylcarnitines glycerophospholipid metabolism fatty acid degradation

Studysummary This study found that serum metabolic profiles differ significantly between polycystic ovary syndrome patients and healthy controls, highlighting potential metabolic markers for diagnosing and prognosing PCOS.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer

The study investigated serum metabolites in 31 women with polycystic ovary syndrome (PCOS) using an untargeted metabolomic approach, comparing them to 31 healthy controls. It identified 146 significantly altered metabolites, with disruptions primarily in lipid metabolism pathways. Notable findings included higher levels of fasting glucose, LH, testosterone, triglycerides, LDL-c, and LH/FSH ratio in PCOS patients, while PRL and HDL-c levels were lower. The study highlighted potential biomarkers for PCOS diagnosis, such as Leu–Ala/Ile–Ala and 3-(4-Hydroxyphenyl) propionic acid, with high diagnostic significance. However, the limited sample size indicated a need for further large-scale research to validate these results.

View this study on bmcmedgenomics.biomedcentral.com →

Discuss this study in the Community →

Research cited in this study

5 / 5 results

research UHPLC/Q-TOFMS-Based Plasma Metabolomics of Polycystic Ovary Syndrome Patients With and Without Insulin Resistance

30 citations , January 2016 in “Journal of Pharmaceutical and Biomedical Analysis”

This study identified trilauric glyceride and decanoylcarnitine as potential biomarkers for diagnosing PCOS in patients with and without insulin resistance, suggesting significant metabolic alterations in these conditions.

research Serum Metabolomics Study of Polycystic Ovary Syndrome Based on Liquid Chromatography–Mass Spectrometry

71 citations , January 2014 in “Journal of Proteome Research”

In this study, distinct metabolic profiles were identified in women with PCOS, suggesting potential biomarkers for diagnosis based on changes in lipid and androgen metabolism.

Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

research Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

1744 citations , August 2006 in “The Journal of Clinical Endocrinology and Metabolism”

This review discusses definitions of polycystic ovary syndrome and reports no new clinical results; the authors support using modified 1990 NIH criteria and acknowledge ongoing evolution as research advances.

research Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome

4809 citations , January 2004 in “Fertility and Sterility”

This review discusses polycystic ovary syndrome, emphasizing its broad range of manifestations and associations with risks like type 2 diabetes and cardiovascular events, but reports no new clinical results.

research Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome (PCOS)

4025 citations , December 2003 in “Human Reproduction”

This review discusses the evolution of diagnostic criteria for polycystic ovary syndrome and emphasizes its association with various metabolic and cardiovascular risks, but it provides no new research findings.